2Sica GL, Choi IH, Zhu G, et al. 137 - H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity, 2003, 18 (6): 849 - 861.
3He YF, Zhang GM, Wang YH, et al.Bloeking programmed death -1 ligand PD- 1 interactions by local gene therapy results in enhancement of antitumor effect of secondary lymphoid tissue ehemokine. Immunol, 2004, 173 (8): 4919-4928.
4Tahiro Shin, Kiyoshi Yoshimura, Takako Shin, et al. In vivo costimulatory role of B7 - DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses.JEM, 2005, 201 (10): 1531-1541.
5Kaufman HL, Deraffele G, Mitcham J, et al. Targeting the local tu t with vaccinia virus expressing B7.1 for the treatment of melanoma.J Clin Invest, 2005, 115 (7): 1903- 1912.
6Kurt RA, Baher A, Wisner KP, et al. Chemokine receptor desensitization in tumor- bearing mice.Cell Immunol, 2001, 207 (2): 81 - 88.
7Curiel TJ, Coukos G, Zou L, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and prediets reduced survival. Nat Med, 2004, 10 (9) : 942 - 949.
9Delman KA, Zager JS, Bennett JJ, et al. Efficacy of multiagent herpes simplex virus amplicon - mediated immtmotherapy as adjuvant treatment for experimental hepatic cancer. Ann Surg, 2002, 236 (3) : 337- 343.
10He YF, Zhang GM, Wang XH, et al.Blocking Programmed Death - 1 Ligand - PD - 1 Interactions by local gene therapy resuits in enhancement of antitumor eEffect of secondary lymphoid tissue chemokine.J Immunol, 2004, 173 (8): 4919-4928.